Cargando…
High Dose Cabergoline in Management of Bilateral Ovarian Hyperstimulation Syndrome: A Case Report
Ovarian hyperstimulation syndrome (OHSS) is an exaggerated response to excess hormones and is also one of the life-threatening iatrogenic complications which is associated with ovulation induction. This syndrome usually occurs in women who receive injectable hormones for the stimulation of egg devel...
Autores principales: | Manalai, Gulparkha, Shirzai, Asadullah, Aalemi, Ahmad Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403006/ https://www.ncbi.nlm.nih.gov/pubmed/34466037 http://dx.doi.org/10.2147/IMCRJ.S318485 |
Ejemplares similares
-
The Effectiveness of Cabergoline for the Prevention of Ovarian Hyperstimulation Syndrome
por: Hosseini, Marzieh Agha, et al.
Publicado: (2011) -
Does the timing of cabergoline administration impact rates of ovarian hyperstimulation syndrome?
por: Rubenfeld, Eryn Sara, et al.
Publicado: (2021) -
Comparison of albumin and cabergoline in the prevention of ovarian hyperstimulation syndrome: A clinical trial study
por: Torabizadeh, Aalie, et al.
Publicado: (2013) -
GnRH antagonist rescue protocol combined with cabergoline versus cabergoline alone in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial
por: Fouda, Usama M., et al.
Publicado: (2016) -
Calcium gluconate infusion is as effective as the vascular endothelial growth factor antagonist cabergoline for the prevention of ovarian hyperstimulation syndrome
por: Naredi, Nikita, et al.
Publicado: (2013)